Literature DB >> 2646319

Systemic senile amyloidosis. Identification of a new prealbumin (transthyretin) variant in cardiac tissue: immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy.

P D Gorevic1, F C Prelli, J Wright, M Pras, B Frangione.   

Abstract

Isolated amyloid fibrils from three cases of systemic senile amyloidosis (SSA) contained subunit proteins with molecular masses of 14 (10-20%), 10-12 (60-80%), and 5-6 kD (5-10%) when fractionated under reducing and dissociating conditions. This grouping was identical to that seen in SKO, a case of familial amyloidotic polyneuropathy (FAP) studied earlier. Amino acid sequencing confirmed that SSA subunit proteins were in fact prealbumin (transthyretin). Complete sequence analysis of one SSA preparation revealed the presence of a new variant Pa (TTr) molecule with a single amino acid substitution of isoleucine for valine at position 122. Further studies used an antiserum specific for SKO IV, a subunit protein of SKO previously shown to correspond to carboxy-terminal 78 residues (positions 49-127) of (TTr). Anti-SKO IV reacted with SSA in tissue at equivalent dilutions to anti-Pa (TTr) and with the 10-12-kD fraction of SSA on Western blots; reactivity was blocked by SKO IV, but not by Pa (TTr). SSA is a form of systemic amyloidosis caused by tissue deposition of Pa (TTr) and its fragments, with shared conformational or subunit antigenicity to at least one form of FAP. Identification of a new variant Pa (TTr) molecule in one case suggests further that SSA may be a genetically determined disease expressed late in life.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2646319      PMCID: PMC303756          DOI: 10.1172/JCI113966

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

1.  Familial primary amyloidosis with severe amyloid heart disease.

Authors:  T FREDERIKSEN; H GOTZSCHE; N HARBOE; W KIAER; K MELLEMGAARD
Journal:  Am J Med       Date:  1962-09       Impact factor: 4.965

2.  Antisera specific for human amyloid reactive with conformational antigens.

Authors:  E C Franklin; D Zucker-Franklin
Journal:  Proc Soc Exp Biol Med       Date:  1972-06

3.  Molecular weight analysis of oligopeptides by electrophoresis in polyacrylamide gel with sodium dodecyl sulfate.

Authors:  R T Swank; K D Munkres
Journal:  Anal Biochem       Date:  1971-02       Impact factor: 3.365

4.  The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes.

Authors:  L A Sternberger; P H Hardy; J J Cuculis; H G Meyer
Journal:  J Histochem Cytochem       Date:  1970-05       Impact factor: 2.479

5.  The interaction of thyroxine with human plasma prealbumin and with the prealbumin-retinol-binding protein complex.

Authors:  A Raz; D S Goodman
Journal:  J Biol Chem       Date:  1969-06-25       Impact factor: 5.157

6.  Isolation of amyloid P component (protein AP) from normal serum as a calcium-dependent binding protein.

Authors:  M B Pepys; A C Dash
Journal:  Lancet       Date:  1977-05-14       Impact factor: 79.321

7.  Chemical coupling of peptides and proteins to polysaccharides by means of cyanogen halides.

Authors:  R Axén; J Porath; S Ernback
Journal:  Nature       Date:  1967-06-24       Impact factor: 49.962

8.  Amyloid in the aged heart: frequency and clinical significance.

Authors:  J R Wright; E Calkins
Journal:  J Am Geriatr Soc       Date:  1975-03       Impact factor: 5.562

9.  The characterization of soluble amyloid prepared in water.

Authors:  M Pras; M Schubert; D Zucker-Franklin; A Rimon; E C Franklin
Journal:  J Clin Invest       Date:  1968-04       Impact factor: 14.808

10.  Characterization of an amyloid fibril protein from senile cardiac amyloid.

Authors:  P Westermark; J B Natvig; B Johansson
Journal:  J Exp Med       Date:  1977-08-01       Impact factor: 14.307

View more
  30 in total

1.  Homozygous transthyretin mutation in an African American Male.

Authors:  Eapen K Jacob; William D Edwards; Mark Zucker; Cyril D'Cruz; Surya V Seshan; Frank W Crow; W Edward Highsmith
Journal:  J Mol Diagn       Date:  2007-02       Impact factor: 5.568

2.  Amyloid seeding of transthyretin by ex vivo cardiac fibrils and its inhibition.

Authors:  Lorena Saelices; Kevin Chung; Ji H Lee; Whitaker Cohn; Julian P Whitelegge; Merrill D Benson; David S Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-28       Impact factor: 11.205

3.  The V122I cardiomyopathy variant of transthyretin increases the velocity of rate-limiting tetramer dissociation, resulting in accelerated amyloidosis.

Authors:  X Jiang; J N Buxbaum; J W Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

4.  A specific test for transthyretin 122 (Val----Ile), based on PCR-primer-introduced restriction analysis (PCR-PIRA): confirmation of the gene frequency in blacks.

Authors:  D R Jacobson
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

5.  Fibril in senile systemic amyloidosis is derived from normal transthyretin.

Authors:  P Westermark; K Sletten; B Johansson; G G Cornwell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

6.  Significance of the amyloidogenic transthyretin Val 122 Ile allele in African Americans in the Arteriosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies.

Authors:  Joel Buxbaum; Alice Alexander; James Koziol; Clement Tagoe; Ervin Fox; Dalane Kitzman
Journal:  Am Heart J       Date:  2010-05       Impact factor: 4.749

7.  Transthyretin Leu 68 in a form of cardiac amyloidosis.

Authors:  M R Almeida; A Hesse; A Steinmetz; B Maisch; K Altland; R P Linke; M A Gawinowicz; M J Saraiva
Journal:  Basic Res Cardiol       Date:  1991 Nov-Dec       Impact factor: 17.165

8.  A homozygous transthyretin variant associated with senile systemic amyloidosis: evidence for a late-onset disease of genetic etiology.

Authors:  D R Jacobson; P D Gorevic; J N Buxbaum
Journal:  Am J Hum Genet       Date:  1990-07       Impact factor: 11.025

9.  Mechanisms of transthyretin amyloidogenesis. Antigenic mapping of transthyretin purified from plasma and amyloid fibrils and within in situ tissue localizations.

Authors:  A Gustavsson; U Engström; P Westermark
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

10.  Transthyretin is an inhibitor of monocyte and endothelial cell interleukin-1 production.

Authors:  L Borish; M S King; J J Mascali; S Johnson; B Coll; L J Rosenwasser
Journal:  Inflammation       Date:  1992-10       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.